title: Fatal myocardial infarction associated with bromocriptine for postpartum lactation suppression.
abstract: Bromocriptine (Parlodel) has attracted widespread controversy for its use for postpartum lactation suppression because of recent reports of cerebral and cardiovascular complications. This case describes a maternal death in which bromocriptine therapy may have triggered myocardial infarction in a patient with asymptomatic coronary artery disease. We suggest its use with caution, especially in patients with identifiable risk factors of coronary artery disease or arteriovascular disease.
authors.affiliation: Department of Obstetrics and Gynaecology, Bankstown/Lidcombe Hospital, Sydney, New South Wales.
authors.forename: S
authors.initials: S
authors.lastname: Dutt
authors.forename: F
authors.initials: F
authors.lastname: Wong
authors.forename: J H
authors.initials: JH
authors.lastname: Spurway
mesh_terms: D000328:Adult; D001971:Bromocriptine / Q000009:adverse effects* / Q000627:therapeutic use; D003328:Coronary Thrombosis / Q000150:complications; D017809:Fatal Outcome; D005260:Female; D006727:Hormone Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D009203:Myocardial Infarction / Q000139:chemically induced*; D011644:Puerperal Disorders / Q000139:chemically induced*
chemical_list: D006727:Hormone Antagonists; D001971:Bromocriptine